Newport Beach, CA11 Active Studies

Atopic Dermatitis Clinical Trials in Newport Beach, CA

Find 11 actively recruiting atopic dermatitis clinical trials in Newport Beach, CA. Connect with local research sites and explore new treatment options.

11
Active Trials
11
Sponsors
3,761
Enrolling

Recruiting Atopic Dermatitis Studies in Newport Beach

About Atopic Dermatitis Clinical Trials in Newport Beach

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 11 atopic dermatitis clinical trials recruiting participants in Newport Beach, CA. These studies are seeking a combined 3,761 participants. Research is being sponsored by Galderma R&D, Sanofi, Johnson & Johnson Enterprise Innovation Inc. and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Newport Beach — FAQ

Are there atopic dermatitis clinical trials in Newport Beach?

Yes, there are 11 atopic dermatitis clinical trials currently recruiting in Newport Beach, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newport Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newport Beach research site will contact you about next steps.

Are clinical trials in Newport Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newport Beach studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 11 active trials in Newport Beach are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated July 18, 2026 from ClinicalTrials.gov